ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
11 hedge funds and large institutions have $766K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 12 closing their positions.
Holders
11
Holders Change
-8
Holders Change %
-42.11%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$362K |
| 2 |
2
Two Sigma Investments
New York
|
$145K |
| 3 |
3
Morgan Stanley
New York
|
$15K |
| 4 |
4
Citigroup
New York
|
$5K |
Top Sellers
| 1 |
1
Wells Fargo
San Francisco,
California
|
$46K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$11K |
| 3 |
3
BlackRock
New York
|
$20K |
| 4 |
EL
4
EMFO LLC
Weston,
Florida
|
$5K |
| 5 |
TSS
5
Two Sigma Securities
New York
|
$143K |
